FKBP5 and type 2 diabetes mellitus: Immunofluorescence staining of FKBP5 revealed a downregulation of the fluorescence intensity and an increase of FKBP5 low expression or even negative β cells, suggesting a decrease of FKBP5 expression in the β cells of T2D patients.